Avanos Medical, Inc.AVNSNYSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+30.9%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+30.9%/yr
Quarterly compound
Percentile
P79
Within normal range
vs 3Y Ago
2.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.04% |
| Q3 2025 | -11.94% |
| Q2 2025 | 2.56% |
| Q1 2025 | -9.57% |
| Q4 2024 | 6.89% |
| Q3 2024 | -2.82% |
| Q2 2024 | 0.84% |
| Q1 2024 | -0.21% |
| Q4 2023 | -0.52% |
| Q3 2023 | -2.35% |
| Q2 2023 | 7.00% |
| Q1 2023 | -11.18% |
| Q4 2022 | 2.69% |
| Q3 2022 | -1.38% |
| Q2 2022 | -4.69% |
| Q1 2022 | 9.00% |
| Q4 2021 | 6.30% |
| Q3 2021 | 0.55% |
| Q2 2021 | -1.08% |
| Q1 2021 | -5.03% |
| Q4 2020 | -2.31% |
| Q3 2020 | 15.26% |
| Q2 2020 | -15.28% |
| Q1 2020 | -6.93% |
| Q4 2019 | 15.47% |
| Q3 2019 | -3.75% |
| Q2 2019 | -0.10% |
| Q1 2019 | -1.59% |
| Q4 2018 | -4.11% |
| Q3 2018 | 10.56% |
| Q2 2018 | 3.95% |
| Q1 2018 | 1.33% |
| Q4 2017 | 10.99% |
| Q3 2017 | -4.14% |
| Q2 2017 | -40.87% |
| Q1 2017 | 0.14% |
| Q4 2016 | 3.41% |
| Q3 2016 | -1.92% |
| Q2 2016 | 3.08% |
| Q1 2016 | 2.17% |